Journal
ANTIVIRAL RESEARCH
Volume 73, Issue 2, Pages 112-117Publisher
ELSEVIER
DOI: 10.1016/j.antiviral.2006.08.002
Keywords
amantadine; rimantadine; matrix gene; resistance; Australia; South East Asia
Categories
Ask authors/readers for more resources
The prevention and control of disease caused by seasonal and potential pandemic influenza viruses is currently managed by the use influenza vaccines and antivirals. The adamantanes (amantadine and rimantadine) were the first antivirals licensed for use against influenza A viruses and have been used extensively in some countries. Since the early 2000s increased resistance to these drugs has been reported especially in the A(H3) viruses. In this study we analysed recent human influenza A strains isolated in Australia and regionally for evidence of resistance to adamantanes and found evidence of significant resistant emerging during 2005. (c) 2006 Elsevier B.V. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available